Your browser doesn't support javascript.
loading
Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes, III: Evaluation of the mammary tumor inhibiting properties.
Reile, H; Spruss, T; Müller, R; Gust, R; Bernhardt, G; Schönenberger, H; Engel, J.
Affiliation
  • Reile H; Institut für Pharmazie, Universität Regensburg, FRG.
Arch Pharm (Weinheim) ; 323(5): 301-6, 1990 May.
Article in En | MEDLINE | ID: mdl-2383173
ABSTRACT
Diastereomeric diaqua[1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II) sulfates and nitrates produce a strong inhibition of the hormone-dependent MXT-M 3.2 mammary carcinoma of the B6D2F1 mouse. Besides an interference in the DNA synthesis in analogy to cisplatin a lowering of the estrogen level due to an interference in steroid biosynthesis is suggested as the mode of action. In contrast to the R,R/S,S configurated diaqua[1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II) salts the corresponding R,S configurated compounds are also markedly active on the hormone-independent MXT-Ovex mammary carcinoma of the B6D2F1 mouse.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Ethylenediamines / Mammary Neoplasms, Experimental / Antineoplastic Agents Limits: Animals Language: En Journal: Arch Pharm (Weinheim) Year: 1990 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Ethylenediamines / Mammary Neoplasms, Experimental / Antineoplastic Agents Limits: Animals Language: En Journal: Arch Pharm (Weinheim) Year: 1990 Document type: Article